Test Price
2,800 AED✅ Home Collection Available
CFHR5 Gene Hemolytic Uremic Syndrome Genetic Test in UAE | 2800 AED | DHA Licensed
UAE Trusted LabExecutive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Complimentary telephonic post-test clinical guidance on result interpretation by a qualified team.
- Insurance: Direct Billing Verification via WhatsApp: +971 54 548 8731.
Test Overview & Methodology
The CFHR5 Gene Hemolytic Uremic Syndrome Genetic Test detects pathogenic variants in the CFHR5 gene associated with atypical hemolytic uremic syndrome (aHUS) and C3 glomerulopathy. This next‑generation sequencing analysis provides comprehensive genetic insight for precise diagnosis and family risk assessment, empowering clinicians and patients to make informed management decisions.
| Feature | Our Test (NGS) | Closest Alternative (Single‑Gene Sanger) |
|---|---|---|
| Precision | Full gene sequencing + copy number analysis | Limited to known hotspots |
| Methodology | Next Generation Sequencing (Illumina® platform) | Sanger sequencing |
| Turnaround Time | 3–4 Weeks | 6–8 Weeks |
Physician Insight & Safety Protocols
“The CFHR5 genetic test is a breakthrough for families affected by atypical hemolytic uremic syndrome, but it must be interpreted alongside renal function markers and family history. I strongly recommend a nephrology consultation after receiving results; genetic findings alone do not replace acute medical care. Early detection can guide life‑saving preventive strategies.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory: Medication Continuation
Do not discontinue prescribed medication without consulting your doctor. This test does not replace ongoing management of hemolytic uremic syndrome.
Exclusion Criteria & Safety Red Flags
- Exclusion: Asymptomatic individuals with no family history of aHUS or C3 glomerulopathy.
- Exclusion: Acute kidney injury stage 3 requiring emergency renal replacement therapy – stabilize first.
- Exclusion: Hemolysed or clotted blood samples; repeat collection required.
- ER Red Flag: Sudden decrease in urine output, confusion, severe hypertension (>180/120 mmHg), or uncontrolled bleeding.
Patient FAQ & Clinical Guidance
1. What is the CFHR5 gene test for hemolytic uremic syndrome?
The CFHR5 gene test is a next-generation sequencing analysis that detects mutations in the CFHR5 gene responsible for atypical hemolytic uremic syndrome, a rare condition causing blood clots and kidney damage.
2. How is the sample collected, and do I need special preparation?
A blood or DNA sample is collected via our home phlebotomy service; no fasting is required, but a prior genetic counselling session to document family history is mandatory.
3. When will I receive the results, and how are they explained?
Results are delivered in 3 to 4 weeks with a comprehensive report; a telephonic post-test clinical guidance session is included to explain findings in the context of your medical history.
UAE Regulatory & Data Privacy Adherence
Data Privacy: All genetic data is protected under Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient consent and clinical safety are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability.
Accreditations: ISO 9001:2015 Certified (INT/EGQ/2509DA/3139). DHA Facility License No. 1143.
Clinical & Logistical Metadata
| Test Name | CFHR5 Gene Hemolytic Uremic Syndrome Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole blood (EDTA) or extracted genomic DNA |
| Methodology Used | Next Generation Sequencing (Illumina® platform) + CNV analysis |
| ICD-10-CM Code | D59.3 |
| LOINC Code | 21673-3 |
| DHA Facility License & Address | License No. 1143 — Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians